• English

Read more about the speakers here:

Dr. Alexander Sulakvelidze


Executive Vice President, Chief Scientific Officer, Intralytix, Inc.

Dr. Alexander Sulakvelidze, Ph.D. is an Executive Vice President and Chief Scientific Officer of Intralytix.  He is an internationally recognized expert in phage technology who was instrumental in securing the first ever FDA-approval for phage based food safety product in the World.  Dr. Sulakvelidze has published extensively on the subject of phage therapy and biocontrol, including co-editing a major book about bacteriophages entitled “Bacteriophages: Biology and Applications”.  He is the author of several issued and pending patents in the field of phage therapy and biocontrol. 

Dr. Christian Jäckel



Christian Jäckel studied Biochemistry at University of Leipzig and received his PhD in Bioorganic Chemistry from Free University of Berlin in 2006. After a PostDoc at ETH Zürich focusing on strategies and methodologies for protein design, he moved to Denmark in 2011 to start a career in biotech industry. Following three years as protein engineer in Novozymes, Christian took a position as scientist and project leader with Chr. Hansen in 2014, where he is developing enzyme products for dairy applications.

Prof. Colin Hill


Principal Investigator, APC Microbiome institute, University College Cork

Colin Hill has a Ph.D in molecular microbiology and is Professor of Microbiology at University College Cork, Ireland. His main interests are in infectious disease, particularly in the role of the gut microbiome (bacteria and bacteriophage) in protecting against microbial infections in the gastrointestinal tract. He is also a Principal Investigator in the APC Microbiome Institute in Cork, a large Science Foundation Ireland supported research centre working with industry devoted to the study of the role of the gut microbiota in health and disease. 

Prof. Giséle LaPointe


Professor. University of Guelph, Canada

Gisèle has recently been awarded the NSERC/Dairy Farmers of Ontario Industrial Research Chair in Dairy Microbiology at the University of Guelph. She has over 20 years of teaching and research experience in food microbiology, biotechnology and food applications of microbial molecular genetics, using systems approaches for studying microbial ecology. Her research aims towards understanding how food components modulate the metabolic activities of microbiota in food and human microbial ecosystems. Her goal is to improve the quality and functionality of food, with a special focus on milk and dairy products.

Dr. Hans van den Brink

Senior Department Manage, Chr. Hansen A/S

Hans van den Brink is currently heading up the Enzymes innovation department at Chr. Hansen. Before this he worked as a fungal specialist in both Chr. Hansen and DSM, specializing in enzyme production. Hans holds a PhD from Leiden University and a master in Human Biology. 

PhD. Henrik Bjørn Nielsen


Chief Scientific Officer, Clinical-Microbiomics A/S

H. Bjørn Nielsen, PhD, Chief Scientific Officer at Clinical-Microbiomics A/S, has since 2008 been a frontrunner in the field of microbiome research, leading to a series of important scientific discoveries including his pioneering work on identification of metagenomic species by co-abundance binning, and a three-pronged association study that links microbiome, serum metabolome and clinical data in pre-diabetic Danes. Current research explores concepts and biology using ultra-high-resolution microbiomics.

Prof. Kevin J. Verstrepen


Direktor, VIB & University of Leuven

PhD. Nicoletta Ravasio


Senior research fellow, CNR ISTM

Nicoletta Ravasio took her PhD in Chemistry at University of Bari in 1987 where she began her activity as CNR researcher. At present she is Senior research fellow at CNR ISTM in Milano where she leads the Biorefinery driven technologies group. Her scientific activity deals with catalytic transformations of renewable raw materials not only from dedicated crops but particularly from residues of the Food Supply chain to produce chemicals and bio-materials.

Dr. Sofie Saerens


Senior Application Manager in Wine, Chr. Hansen A/S, Denmark

Sofie Saerens has a PhD (2007) in Bioscience Engineering from KULeuven, Belgium. Passionate about yeast, she did an industrial postdoc in 2007 (Lab for Molecular Cell Biology) and in 2009 (Lab for Systems Biology), VIB, Leuven to develop tailor-made yeast for the food and beverage industry. In 2011, Sofie moved to Denmark to join the Wine Department at Chr Hansen A/S. Currently, she is Senior Application Manager, responsible for new business & product development within fermented beverages with a focus on yeast and bacterial technologies. Sofie has 3 patents, 6 patent applications and 15 articles.

Prof. Sylvain Moineau


Professor of Microbiology, Université Laval (Québec city, Canada)

Professor Moineau is based in the Department of Biochemistry, Microbiology and Bioinformatics at Université Laval and holds the Canada Research Chair in Bacteriophages. He curates the world’s largest collection of phages. His group aims at understanding phage-bacteria interactions, including his landmark discoveries on CRISPR-Cas systems. He has been ranked amongst the most cited microbiologists in the world for the past four years. In 2017, he was awarded the NSERC John Polanyi Award, Canadian Society of Microbiologists Murray Award for Career Achievement, DuPont Excellence Medal and was elected in the Academy of Sciences of the Royal Society of Canada. 

Dr. Wolfgang Aehle


Dr. Wolfgang Aehle obtained his Ph.D. in organic chemistry from Braunschweig Technical University in 1986. From 1987, at a PostDoc position at the German Research Centre for Biotechnology (GBF) in Braunschweig, Dr Aehle specialised in the field of protein structure, computer assisted protein design and protein engineering within an industrial collaboration with Solvay enzymes (Brussels, BE). In 1991 Dr Aehle accepted a position as protein engineer in the R&D Department of Gist-Brocades (now part of DSM) in Delft, The Netherlands. When the industrial enzyme division of Gist-Brocades was sold to the American biotech pioneer Genencor International in 1995, Dr Aehle became employee of the company’s R&D department in Leiden (NL). In 2008, Dr Aehle joined BRAIN AG, where he is responsible for the corporate development in the field of performance proteins and enzymes and new business development for enzymes.